US Bancorp’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.7M | Buy |
130,847
+552
| +0.4% | +$57.6K | 0.02% | 384 |
|
|
2025
Q1 | $15.2M | Sell |
130,295
-724
| -0.6% | -$84.4K | 0.02% | 365 |
|
|
2024
Q4 | $11.1M | Sell |
131,019
-2,107
| -2% | -$178K | 0.01% | 416 |
|
|
2024
Q3 | $12M | Buy |
133,126
+421
| +0.3% | +$37.8K | 0.02% | 400 |
|
|
2024
Q2 | $10.7M | Sell |
132,705
-800
| -0.6% | -$64.4K | 0.01% | 408 |
|
|
2024
Q1 | $10.7M | Sell |
133,505
-9,919
| -7% | -$792K | 0.01% | 415 |
|
|
2023
Q4 | $11.4M | Buy |
143,424
+4,653
| +3% | +$370K | 0.02% | 395 |
|
|
2023
Q3 | $9.7M | Sell |
138,771
-961
| -0.7% | -$67.2K | 0.02% | 403 |
|
|
2023
Q2 | $10M | Buy |
139,732
+4,241
| +3% | +$305K | 0.02% | 404 |
|
|
2023
Q1 | $8.36M | Sell |
135,491
-3,301
| -2% | -$204K | 0.01% | 440 |
|
|
2022
Q4 | $10.7M | Sell |
138,792
-11,614
| -8% | -$896K | 0.02% | 389 |
|
|
2022
Q3 | $6.71M | Sell |
150,406
-112,476
| -43% | -$5.02M | 0.01% | 454 |
|
|
2022
Q2 | $10.1M | Buy |
262,882
+260,944
| +13,465% | +$9.99M | 0.02% | 380 |
|
|
2022
Q1 | $80K | Sell |
1,938
-8,938
| -82% | -$369K | ﹤0.01% | 2372 |
|
|
2021
Q4 | $411K | Sell |
10,876
-224
| -2% | -$8.47K | ﹤0.01% | 1622 |
|
|
2021
Q3 | $366K | Buy |
11,100
+1,590
| +17% | +$52.4K | ﹤0.01% | 1671 |
|
|
2021
Q2 | $641K | Buy |
9,510
+136
| +1% | +$9.17K | ﹤0.01% | 1418 |
|
|
2021
Q1 | $531K | Buy |
9,374
+313
| +3% | +$17.7K | ﹤0.01% | 1464 |
|
|
2020
Q4 | $738K | Buy |
9,061
+630
| +7% | +$51.3K | ﹤0.01% | 1243 |
|
|
2020
Q3 | $601K | Buy |
8,431
+5,678
| +206% | +$405K | ﹤0.01% | 1231 |
|
|
2020
Q2 | $226K | Sell |
2,753
-351
| -11% | -$28.8K | ﹤0.01% | 1684 |
|
|
2020
Q1 | $183K | Buy |
3,104
+1,258
| +68% | +$74.2K | ﹤0.01% | 1684 |
|
|
2019
Q4 | $191K | Buy |
1,846
+653
| +55% | +$67.6K | ﹤0.01% | 1851 |
|
|
2019
Q3 | $25K | Buy |
1,193
+371
| +45% | +$7.78K | ﹤0.01% | 2745 |
|
|
2019
Q2 | $21K | Buy |
+822
| New | +$21K | ﹤0.01% | 2852 |
|